Filing Flows › Cytosorbents (CTSO) › Recalls, complaints & regulation
Cytosorbents (CTSO): EPA violations and clinical trials
Cytosorbents (CTSO) beyond its filings: 1 EPA-regulated facility in violation, $4K in penalties over five years; 2 active clinical trials.
EPA facilities in violation
| Facility (as registered) | City | Status | Penalties |
|---|---|---|---|
| CYTOSORBENTS MEDICAL INC | Princeton, NJ | Violation Identified | — |
Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.
Cytosorbents' latest quarter
Cytosorbents, Q2 2026: revenue $9.6M (+0.2% year over year), operating margin -27.4%, net loss $4.4M, operating cash flow −$583K. The chart follows the revenue to costs, profit and cash.
Questions
Has Cytosorbents been fined by the EPA?
The 3 EPA-regulated facilities on file under its name drew $4K in penalties over five years; 1 is in violation now.
How many clinical trials does Cytosorbents have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.